2 stories about Amgen
חברת ה תרופות טבע Teva

Teva Agrees to Stop Selling Amgen Generic Following Patent Infringement Settlement

03.01.19|Lilach Baumer
In December, Teva reached a confidential settlement and licensing agreement with drug manufacturer Neos Therapeutics, regarding its generic version for Neos' ADHD drug

Drug Developer Entera Bio Down on Nasdaq Following Amgen Deal

12.12.18|Lilach Baumer
The deal, announced Tuesday, could see Entera receive up to $270 million in aggregate payments